Loading

Current Research in Emergency Medicine
[ ISSN : 2832-5699 ]


HBsAg Seroprevalance and Affecting Factors in Patients Attending Emergency Department

Research Article
Volume 2 - Issue 3 | Article DOI : 10.54026/CREM/1026


Oladapo BE1 , Avcil M2 , Demirag S3*

1MD, Specialist, Department of Emergency Medicine, Ayd?n Adnan Menderes University, School of Medicine,
Turkey
2MD, Associate Professor, Department of Emergency Medicine, Ayd?n Adnan Menderes University, School of
Medicine, Turkey
3MD, PhD, Professor, Department of Family Medicine, Ayd?n Adnan Menderes University, School of
Medicine, Turkey

Corresponding Authors

Serpil Demirag, Department of Family Medicine, Adnan Menderes University, School of Medicine, Turkey

Keywords

Emergency; HBsAg; Anti-HBs; Seroprevalence; Hepatitis; Infection

Received : March 18, 2022
Published : April 04, 2022

Abstract

Aim: To determine the seroprevalence of HBsAg in the emergency unit while determining risk for transmission and associated socidemographics.

Method: In this study, we accessed the records of 693 patients with various complaints, who had their HBsAg checked in the emergency department, retrospectively. Binominal logistic regression and chi-square test was used for data analysis to determine predictors of HBsAg seropositivity.

Results: Of the total 693 patients, 57.3% (n=397) of the patients were male and the mean age was 53.8±21.6 (4-99). 58.6% (n=405) of the patients lived in the urban area while 95.5% (n=662) had health insurance. 41.1% (n=288) of the admitted patients had at least one chronic disease. The HBsAg seroprevalence of those included in the study was 3.3%. The highest prevalence of HBsAg seropositivity was recorded in the 41-60 age group with a rate of 5.2%. Anti-HBs seroprevalence was 44.6% (n=311), Anti-HCV seroprevalence was 0.6% (n=4) and Anti-HIV was 0.3% (n=3). Lower Anti-HBs was found as a significant risk factor for Hepatitis B infection (p=0.003), patients who had non-protective Anti-HBs levels were at tenfold risk of contracting Hepatitis B compared to their Anti-HBs positive counterparts.

Conclusion: The prevalence of hepatitis B in our study was at an intermediate epidemic level. Testing at every opportunity even in the emergency service is a suitable strategy for the prevention and control of hepatitis B. The findings are similar to other available data in our region. We suggest that low Anti-HBs level is the most significant risk factor for HBsAg seropositivity. More expanded and comprehensive studies should be carried in the whole population.